State Health Investment Project: Impact Evaluation Endline Survey, 2017
Nigeria, 2017
Get Microdata
Reference ID
NGA_2017_HRBFIE-EL_v01_M
Producer(s)
Eeshani Kandpal (World Bank)
Created on
Dec 05, 2022
Last modified
Aug 28, 2024
Page views
140383
Downloads
507
- Data files
- cardio_drugs_noid.dta
- Catchment_Area_noid.dta
- decr_services_noid.dta
- diagnostic_kits_noid.dta
- FP_drugs_noid.dta
- general_drugs_noid.dta
-
Health Facility
(HF1)_noid.dta - HF1_Sect08_noid.dta
- HF1_sect10A_noid.dta
- HF1_Sect10B_noid.dta
- incr_services_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- malaria_drugs_noid.dta
- obstetric_care_noid.dta
- Q1611_positions_noid.dta
- services_noid.dta
- TB_drugs_noid.dta
- vaccines_noid.dta
- anc_patients_noid.dta
- HF3_HCP_Info_noid.dta
- HF4_HCP_Info_noid.dta
- HF4_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient DIRECT
OBSERVATION
(HF3_HF4)_noid.dta - HF5_ASSETS_noid.dta
- HF5_LIVESTOCK_noid.dta
- HF5_patients_noid.dta
- HF6_ASSETS_noid.dta
- HF6_LIVESTOCK_noid.dta
- HF6_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient EXIT
INTERVIEW
(HF5_HF6)_noid.dta -
Health Care
Provider
Interviews
(HF7)_noid.dta - HF7_Q202_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- staff_roster_noid.dta
- Durable_Goods_noid.dta
- hhroster_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
NSHIP IE
Midline
Household Women
Questionnaire_noid.dta - Q16_13_noid.dta
- S5C_Assets_noid.dta
- S9_Vaccines_noid.dta
- Sec_05B_noid.dta
- Sec_06A_noid.dta
- Sec_06B_noid.dta
- Sec_06C_noid.dta
- Sec_07_noid.dta
(Id)
Data file: general_drugs_noid.dta
Overview
Valid:
14157
Invalid:
-
Minimum:
1
Maximum:
29
Type:
Discrete
Decimal:
0
Start:
1
End:
2
Width:
2
Range:
1 - 29
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | 329 |
2.3%
|
|
| 2 | 925 |
6.5%
|
|
| 3 | 781 |
5.5%
|
|
| 4 | 694 |
4.9%
|
|
| 5 | 625 |
4.4%
|
|
| 6 | 200 |
1.4%
|
|
| 7 | 90 |
0.6%
|
|
| 8 | 54 |
0.4%
|
|
| 9 | 756 |
5.3%
|
|
| 10 | 736 |
5.2%
|
|
| 11 | 783 |
5.5%
|
|
| 12 | 745 |
5.3%
|
|
| 13 | 641 |
4.5%
|
|
| 14 | 365 |
2.6%
|
|
| 15 | 529 |
3.7%
|
|
| 16 | 572 |
4%
|
|
| 17 | 469 |
3.3%
|
|
| 18 | 782 |
5.5%
|
|
| 19 | 626 |
4.4%
|
|
| 20 | 129 |
0.9%
|
|
| 21 | 61 |
0.4%
|
|
| 22 | 435 |
3.1%
|
|
| 23 | 657 |
4.6%
|
|
| 24 | 263 |
1.9%
|
|
| 25 | 359 |
2.5%
|
|
| 26 | 769 |
5.4%
|
|
| 28 | 564 |
4%
|
|
| 29 | 218 |
1.5%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.